Role of pharmacologically active metabolites in drug discovery and development

被引：104

作者：

Fura, A ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Metab & Pharmacokinet, Princeton, NJ 08534 USA

来源：

DRUG DISCOVERY TODAY | 2006年 / 11卷 / 3-4期

关键词：

D O I：

10.1016/S1359-6446(05)03681-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Pharmacologically active metabolites can contribute significantly to the overall therapeutic and adverse effects of drugs. Therefore, to fully understand the mechanism of action of drugs, it is important to recognize the role of active metabolites. Active metabolites can also be developed as drugs in their own right. Using illustrative examples, this paper discusses a variety of biotransformation reactions that produce active metabolites and their structure-activity relationships. The paper also describes the role and significance of active metabolites in drug discovery and development, various experimental observations that can be used as indicators of their presence, and methods that can be used to assess their biological activities and contribution to the overall therapeutic and adverse effects of drugs.

引用

页码：133 / 142

页数：10

共 72 条

[21] Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity [J].

Guengerich, FP .

CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (06) :611-650

[22] Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency [J].

Harrower, ADB .

CLINICAL PHARMACOKINETICS, 1996, 31 (02) :111-119

[23] TERFENADINE-KETOCONAZOLE INTERACTION - PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC CONSEQUENCES [J].

HONIG, PK ;

WORTHAM, DC ;

ZAMANI, K ;

CONNER, DP ;

MULLIN, JC ;

CANTILENA, LR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (12) :1513-1518

[24] Hypoglycemic effect of S(-)-hydroxyhexamide, a major metabolite of acetohexamide, and its enantiomer R(+)-hydroxyhexamide [J].

Imamura, Y ;

Sanai, K ;

Seri, K ;

Akita, H .

LIFE SCIENCES, 2001, 69 (16) :1947-1955

[25] Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole [J].

Jeng, S ;

Chanchairujira, T ;

Jusko, W ;

Steiner, R .

TRANSPLANTATION, 2003, 75 (06) :792-795

[26] Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen [J].

Johnson, MD ;

Zuo, H ;

Lee, KH ;

Trebley, JP ;

Rae, JM ;

Weatherman, RV ;

Desta, Z ;

Flockhart, DA ;

Skaar, TC .

BREAST CANCER RESEARCH AND TREATMENT, 2004, 85 (02) :151-159

[27] IMPORTANCE OF THE ALKYLAMINOETHOXY SIDE-CHAIN FOR THE ESTROGENIC AND ANTI-ESTROGENIC ACTIONS OF TAMOXIFEN AND TRIOXIFENE IN THE IMMATURE RAT UTERUS [J].

JORDAN, VC ;

GOSDEN, B .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1982, 27 (03) :291-306

[28] Possible role of metabolite in flosequinan-related mortality [J].

Kamali, F ;

Edwards, C .

CLINICAL PHARMACOKINETICS, 1995, 29 (06) :396-403

[29] IDENTIFICATION AND BIOLOGICAL-ACTIVITY OF TAMOXIFEN METABOLITES IN HUMAN-SERUM [J].

KEMP, JV ;

ADAM, HK ;

WAKELING, AE ;

SLATER, R .

BIOCHEMICAL PHARMACOLOGY, 1983, 32 (13) :2045-2052

[30] Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels [J].

Knegtering, R ;

Baselmans, P ;

Castelein, S ;

Bosker, F ;

Bruggeman, R ;

van den Bosch, RJ .

AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (05) :1010-1012

← 1 2 3 4 5 6 7 8 →